Latest Breaking News On - Total vascular events - Page 1 : comparemela.com

Marc Bonaca, MD, MPH: Benefit of Rivaroxaban for High-Risk Patients with PAD

Presented at AHA 2023, new analyses of VOYAGER PAD suggest the benefit of rivaroxaban plus aspirin for high-risk and complex populations with PAD.

United statesMarcp bonacaAmerican heart association scientific sessionsAmerican heart associationUniversity of colorado anschutz medical campusScientific sessionsColorado anschutz medical campusLow dose rivaroxaban plus aspirinMyocardial infarctionPeripheral artery disease withWithout concomitant coronary artery diseaseTotal vascular eventsFragile patientsPeripheral artery disease

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarcp bonacaMarc bonacaJanssen scientific affairsJanssen pharmaceuticals incExchange commissionDrug administrationJanssenus janssen scientific affairsDivision of cardiovascular medicineNone of janssen scientific affairsDepartment of medicineCompanies of johnsonJanssen pharmaceutical companies of johnsonAmerican heart associationUniversity of colorado anschutz medical campusJanssen pharmaceutical companies